Axol Bioscience raised €3.8M in a funding round in Apr 2022. The company is based in Cambridge, UK. Investors in the round: Calculus Capital, Dr Jonathan Milner, Meltwind and 2 others. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
